ReviewPediatric radiology2026
Abdominal vascular imaging with ferumoxytol - how we do it.
Review in Pediatric radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MR angiography with ferumoxytol expands the toolset for imaging the pediatric abdominal vasculature. As an iron-based blood pool contrast agent, ferumoxytol allows for high-resolution imaging of the abdominal vessels that is not dependent on precise timing of contrast phases and can be used in patients with a contraindication to gadolinium-based contrast agents. At our institution, it has proven useful for abdominal indications including vascular mapping in the settings of portal hypertension, portosystemic shunts, and abdominal transplant evaluation, as well as for investigation of vascular malformations and vasculitis. Others have demonstrated its utility in tumor imaging, especially with hepatic tumors. In this review, we describe our protocol for ferumoxytol-enhanced MR angiography and discuss its various pediatric abdominal applications.
Indexed as
Identifiers
41569328What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.